Effect of fingolimod on platelet count among multiple sclerosis patients
Background: While many studies have previously focused on fingolimod′s effect on immune cells, the effect it has on circulating and local central nervous system platelets (Plts) has not yet been investigated. This study will elucidate what effects fingolimod treatment has on multiple sclerosis (MS)...
Main Authors: | Mehrdad Farrokhi, Ali Amani Beni, Masoud Etemadifar, Ali Rezaei, Leah Rivard, Aryan Rafiee Zadeh, Nahid Sedaghat, Milad Ghadimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2015;volume=6;issue=1;spage=125;epage=125;aulast=Farrokhi |
Similar Items
-
Fingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
by: Masoud Etemadifar, et al.
Published: (2017-02-01) -
The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population
by: Morteza Abdar, et al.
Published: (2017-03-01) -
Fingolimod in children with Rett syndrome: the FINGORETT study
by: Yvonne Naegelin, et al.
Published: (2021-01-01) -
Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018-03-01) -
Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review
by: M. Martinot, et al.
Published: (2020-03-01)